AI assistant
BIO-TECHNE Corp — Director's Dealing 2018
Aug 9, 2018
30718_dirs_2018-08-09_11f7f0a6-7768-4c84-9c51-4ed179f18e13.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2018-08-07
Reporting Person: Eansor Norman David (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-07 | Common Stock | M | 1199.00 | $0.00 | Acquired | 3465.00 | Direct |
| 2018-08-07 | Common Stock | F | 348.00 | $180.14 | Disposed | 3117.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-08-07 | Restricted Stock Units | $ | M | 1199.00 | Disposed | Common Stock (1199.00) | Direct | |
| 2018-08-07 | Restricted Stock Units | $ | D | 301.00 | Disposed | Common Stock (301.00) | Direct | |
| 2018-08-07 | Stock Options (Right to buy) | $108.49 | D | 1881.00 | Disposed | 2022-08-07 | Common Stock (1881.00) | Direct |
| 2018-08-08 | Restricted Stock Units | $ | A | 2537.00 | Acquired | Common Stock (2537.00) | Direct | |
| 2018-08-08 | Stock Options (Right to buy) | $177.32 | A | 18066.00 | Acquired | 2025-08-08 | Common Stock (18066.00) | Direct |
| 2018-08-08 | Stock Options (Right to buy) | $177.32 | A | 13550.00 | Acquired | 2025-08-08 | Common Stock (13550.00) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Units | $ | Common Stock (2287.00) | 2287.00 | Direct | |
| Restricted Stock Units | $ | Common Stock (2174.00) | 2174.00 | Direct | |
| Stock Option (Right to Buy) | $108.49 | 2022-08-07 | Common Stock (12500.00) | 12500.00 | Direct |
| Stock Option (Right to Buy) | $94.35 | 2021-08-12 | Common Stock (15000.00) | 15000.00 | Direct |
| Stock Options (Right to buy) | $125.05 | 2024-08-09 | Common Stock (11982.00) | 11982.00 | Direct |
| Stock Options (Right to buy) | $125.05 | 2024-08-09 | Common Stock (15976.00) | 15976.00 | Direct |
| Stock Options (Right to buy) | $106.59 | 2023-08-18 | Common Stock (18819.00) | 18819.00 | Direct |
| Stock Options (Right to buy) | $106.59 | 2023-08-18 | Common Stock (14114.00) | 14114.00 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2: On 8/7/2018, the Board of Directors authorized discretionary vesting for 1,199 performance RSUs. The remainder of the performance RSUs were forfeited.
F3: On 8/7/2018, the Board of Directors authorized discretionary vesting for 7,494 performance options. The remainder of the performance options were forfeited.
F4: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F5: Vests 4,517 shares each on 8/8/2019, 8/8/2020 and 4,516 shares each on 8/8/2021, 8/8/2022.
F6: Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7: Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8: 3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
F9: 3,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.
F10: Vest 3,994 shares on each 8/9/2018, 8/9/2019, 8/9/2020, 8/9/2021
F11: Vests 4,705 shares on 8/18/17, 8/18/18, and 8/18/19 and 4,704 shares on 8/18/20.